IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.


Add photos to showcase IconOVir’s culture


Add IconOVir’s values

Insider experiences

Share your experience of working at IconOVir

Mark McCamish
President & CEO
Heba Nowyhed
Head of Translational Research
Benjamin Stone
Head of Business Operations
Michael Lyman
Head of Discovery Research
Nicole Van De Leuv
Head of Legal
Juli Degraw
Head of CMC & Product Development
Christopher Wilfong
Corporate Development & Strategy Advisor
Sean Algeo
Controller & Treasurer

Add your teams to show how people work together at IconOVir

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.